Oxycodon

OXYCODONE Struktur
76-42-6
CAS-Nr.
76-42-6
Bezeichnung:
Oxycodon
Englisch Name:
OXYCODONE
Synonyma:
percocet;Oxycodon;endone;Percodan;Dihydrohydroxycodeinone;14-Hydroxydihydrocodeinone;Oxicon;oxanest;Oxicone;OXYCODONE
CBNumber:
CB5166312
Summenformel:
C18H21NO4
Molgewicht:
315.36
MOL-Datei:
76-42-6.mol

Oxycodon Eigenschaften

Schmelzpunkt:
218-220°
Siedepunkt:
454.92°C (rough estimate)
Dichte
1.2164 (rough estimate)
Brechungsindex
1.5740 (estimate)
Flammpunkt:
9℃
storage temp. 
2-8°C
Löslichkeit
DMF: 20 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 10 mg/ml
Aggregatzustand
A neat solid
pka
8.53(at 25℃)
Farbe
Long rods from EtOH
EPA chemische Informationen
Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)- (76-42-6)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher F,T
R-Sätze: 11-23/24/25-39/23/24/25
S-Sätze: 7-16-36/37-45
RIDADR  1544
WGK Germany  1
HazardClass  6.1(a)
PackingGroup  II
HS Code  2939110000
Giftige Stoffe Daten 76-42-6(Hazardous Substances Data)
Toxizität LD50 intraperitoneal in mouse: 320mg/kg
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H336 Kann Schläfrigkeit und Benommenheit verursachen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Schläfrigkeit und Benommenheit) Warnung P261, P271, P304+P340, P312,P403+P233, P405, P501
H362 Kann Säuglinge über die Muttermilch schädigen. Reproductive toxicity, effects on or via lactation Additional category P201, P260, P263, P264, P270,P308+P313
Sicherheit
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P260 Dampf/Aerosol/Nebel nicht einatmen.
P263 Kontakt während der Schwangerschaft /und der Stillzeit vermeiden.
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Oxycodon Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Oxycodone (Item No. 15465) is an analytical reference material categorized as an opioid. Oxycodone is regulated as a Schedule II compound in the United States. This product is intended for research and forensic applications.

Verwenden

Analgesic (narcotic).

Definition

oxycodone: An opioid, C18H21N2,similar in structure to codeine butwith a –OH group in codeine replacedby a carbonyl group. It is ananalgesic often used for the treatmentof chronic pain. It is also usedillegally and is a controlled substancein most countries.

Biologische Funktion

Oxycodone is nearly 10 times as strong as codeine, with absorption equal to that of orally administered morphine. Neither hydromorphone nor oxycodone is approved for use in children, and hydromorphone is contraindicated in obstetrical analgesia and in asthmatics.

Allgemeine Beschreibung

Oxycodone is synthesized from the natural opium alkaloidthebaine. Oxycodone is the 14 beta-hydroxyl version of hydrocodone.This additional functional group gives oxycodonegreater potency (1.5 times orally) than hydrocodone presumablyby increasing receptor affinity. The oral bioavailabilityof oxycodone is 65% to 87%. The metabolism of oxycodonefollows the similar pattern of opioid metabolism withN-demethylation, O-demethylation, and their glucuronides allidentified. Per the manufacturer, the analgesic effect of oxycodonecorrelates well with oxycodone plasma concentrations,not the minimal amount of oxymorphone formed, thusoxycodone is not assumed to be a prodrug. There are no largescalestudies of oxycodone used for analgesia in CYP2D6poor metabolizers that can confirm this.
Oxycodone is marketed in combination with acetaminophen(Percocet), aspirin (Percodan), and ibuprofen(Combunox). It has been available for over 50 years as animmediate-release tablet, and in 1995 an extended-releasetablet was approved by the FDA (OxyContin). OxyContin ismanufactured in eight strengths from 10 to 160 mg, and thehigh-dose preparations quickly became attractive to drugabusers. The extended-release tablets are crushed and theninjected or snorted to give an immediate high. The DrugAbuse Warning Network (DAWN) is a public health surveillancesystem that monitors drug-related emergency roomvisits and drug-related deaths. In 1995, they estimated that598,542 emergency room visits involved the nonmedical useof a pharmaceutical (e.g., antidepressant, anxiolytic, stimulant).Of these ER visits, 160,363 visits were attributed toopiates with an estimated 42,810 involving oxycodone or anoxycodone combination. Methadone and hydrocodone/combinationswere estimated to be similar to oxycodone.

Pharmakologie

Oxycodone is a potent semisynthetic opioid that has been in use for many years. In addition to actions at the MOP receptor, it may also have analgesic effects mediated via the KOP receptor, resulting in incomplete crosstolerance with morphine. It has a good oral bioavailability, and its plasma concentrations are more predictable than those of morphine after oral administration. It is available in both long- and short-acting oral preparations and, more recently, in a parenteral formulation. Oral oxycodone is roughly 1.5 times more potent than oral morphine.

Sicherheitsprofil

Poison by intraperitoneal route. Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic fumes of NOx.

Oxycodon Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

76-42-6(Oxycodon)Verwandte Suche:


  • OXYCODONE
  • 4,5-alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-morphinan-6-on
  • 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-morphinan-6-on
  • 4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
  • eubine(france)
  • Eucodalum
  • Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-
  • Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-
  • NSC-19043
  • oxanest
  • Oxicon
  • Oxicone
  • Oxycodeinone
  • pancodoneretard(unitedkingdom)
  • Percobarb
  • supendol(canada)
  • 4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
  • 4aH-8,9c-Iminoethanophenanthro(4,5-bcd)furan-5(6H)-one, 7,7a,8,9-tetrahydro-7a-hydroxy-3-methoxy-12-methyl-
  • 5-epoxy-14-hydroxy-3-methoxy-17-methyl-(5alpha)-morhinan-6-on
  • 7,8-dihydro-14-hydroxy-codeinon
  • OXYCODONE/4,5-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE
  • 4Ah-8,9C-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one, 7,7A,8,9-tetrahydro-7A-hydroxy-3-methoxy-12-methyl-
  • Oxycodone, 1.0 mg/mL
  • Oxycodone CII (200 mg)
  • Oxycodone solution
  • Codeinone, 7,8-dihydro-14-hydroxy-
  • Codeinone, dihydro-14-hydroxy-
  • Codeinone, dihydrohydroxy-
  • dihydro-14-hydroxy-codeinon
  • Dihydro-14-hydroxycodeinone
  • Dihydrohydroxycondeinone
  • Dihydrone
  • Dihydroxycodeinone
  • Diphydrone
  • endine(australia)
  • Tekodin (free base)
  • Pancodone
  • 3-O-(Methyl)oxymorphone
  • 6-Oxo-14-hydroxy-7,8-dihydrocodeine
  • 7,8-Dihydro-14-hydroxycodeinone
  • Codeinone, 7,8-dihydro-14-hydroxy- (6CI, 7CI)
  • Morphinan-6-one, 4,5a-epoxy-14-hydroxy-3-methoxy-17-methyl- (8CI)
  • Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5a)- (9CI)
  • Oxymorphone 3-methyl ether
  • OXYCODONE Basic information
  • BRUQQQPBMZOVGD-XFKAJCMBSA-N
  • Oxycodone (CRM)
  • Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5α)-
  • (-)-Oxycodone
  • Oxycodone CII (1485191)
  • Oxycodon
  • percocet
  • Percodan
  • Dihydrohydroxycodeinone
  • endone
  • 14-Hydroxydihydrocodeinone
  • Oxycodone [Controlled Substance
  • 76-42-6
Copyright 2019 © ChemicalBook. All rights reserved